{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:19:29Z","timestamp":1784002769052,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Medical University of Gda\u0144sk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032164","name":"Univerzita Obrany","doi-asserted-by":"publisher","award":["DZRO-FVZ22-ZHN II"],"award-info":[{"award-number":["DZRO-FVZ22-ZHN II"]}],"id":[{"id":"10.13039\/100032164","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["25-16937S"],"award-info":[{"award-number":["25-16937S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2022\/47\/D\/NZ7\/01043"],"award-info":[{"award-number":["2022\/47\/D\/NZ7\/01043"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019624","name":"University Hospital Hradec Kralove","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014911","name":"Ministerstvo Obrany \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118537","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:57:15Z","timestamp":1757768235000},"page":"118537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidines"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-6850","authenticated-orcid":false,"given":"Vladimir","family":"Finger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Vrbicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6693-6061","authenticated-orcid":false,"given":"Lubica","family":"Muckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Prchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-0967","authenticated-orcid":false,"given":"Jan","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6376-8701","authenticated-orcid":false,"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2926-3798","authenticated-orcid":false,"given":"Michaela","family":"Hympanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-3980","authenticated-orcid":false,"given":"Ales","family":"Sorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9196-9073","authenticated-orcid":false,"given":"Marketa","family":"Benkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bartacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1861-8979","authenticated-orcid":false,"given":"Pavel","family":"Drabina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Kovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Fikejzlov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Ozhelevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Jagob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-9591","authenticated-orcid":false,"given":"Jana","family":"Zdarova-Karasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0628-9865","authenticated-orcid":false,"given":"Jitka","family":"Odvarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"Kaderavkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-0876","authenticated-orcid":false,"given":"Tomas","family":"Rozsypal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ewa Greber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzesimir","family":"Ciura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3336-3874","authenticated-orcid":false,"given":"Jiri","family":"Janousek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4600-8409","authenticated-orcid":false,"given":"Martin","family":"Kratky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-2872","authenticated-orcid":false,"given":"Ivone C.","family":"Igreja Sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Bostik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-9147","authenticated-orcid":false,"given":"Radek","family":"Sleha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118537_bib1","author":"Global Tuberculosis Report","year":"2024"},{"key":"10.1016\/j.biopha.2025.118537_bib2","author":"WHO","year":"2022","journal-title":"Consol. Guidel. Tuberc. Modul. 4 Treat. Drugsusceptible Tuberc. Treat."},{"key":"10.1016\/j.biopha.2025.118537_bib3","series-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.biopha.2025.118537_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1314385","article-title":"FDA approval of bedaquiline\u2014the benefit-risk balance for drug-resistant tuberculosis","volume":"371","author":"Cox","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118537_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40265-014-0241-5","article-title":"Delamanid: first global approval","volume":"74","author":"Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2025.118537_bib6","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-019-01207-9","article-title":"Pretomanid: first approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2025.118537_bib7","article-title":"Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review","volume":"4","author":"Mallick","year":"2022","journal-title":"JACAntimicrob. Resist"},{"key":"10.1016\/j.biopha.2025.118537_bib8","first-page":"3252","article-title":"Delamanid resistance: update and clinical management","volume":"71","author":"Nguyen","year":"2020"},{"key":"10.1016\/j.biopha.2025.118537_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106953","article-title":"Pretomanid resistance: an update on emergence, mechanisms and relevance for clinical practice","volume":"62","author":"Nguyen","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2025.118537_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115611","article-title":"2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1","volume":"258","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118537_bib11","first-page":"1099","article-title":"Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs","volume":"13","author":"Kumari","year":"2023","journal-title":"Life Basel Switz."},{"key":"10.1016\/j.biopha.2025.118537_bib12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jps.20331","article-title":"Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent imexon using dimethyl sulfoxide as solubilising and stabilising agent","volume":"94","author":"den Brok","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118537_bib13","first-page":"1987","article-title":"Comparison of commonly used and new methods to determine small molecule Non-Specific binding to human liver microsomes","volume":"113","author":"Wang","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118537_bib14","doi-asserted-by":"crossref","unstructured":"S.N.R. Gajula, S.A. Vora, A.G. Dikundwar, R. Sonti, In Vitro Drug Metabolism Studies Using Human Liver Microsomes | IntechOpen, (2023). \u3008https:\/\/www.intechopen.com\/chapters\/84232\u3009 (accessed August 19, 2025). https:\/\/doi.org\/10.5772\/intechopen.84232.","DOI":"10.5772\/intechopen.84232"},{"key":"10.1016\/j.biopha.2025.118537_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2016.04.009","article-title":"Lipophilicity and biomimetic properties measured by HPLC to support drug discovery","volume":"130","author":"Valk\u00f3","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2025.118537_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5599\/admet.530","article-title":"The role and impact of high throughput biomimetic measurements in drug discovery","volume":"6","author":"Bunally","year":"2018","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.biopha.2025.118537_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ansa.202200004","article-title":"Biomimetic chromatography-A novel application of the chromatographic principles","volume":"3","author":"Valko","year":"2022","journal-title":"Anal. Sci. Adv."},{"key":"10.1016\/j.biopha.2025.118537_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5599\/admet.529","article-title":"Leveraging chromatography based physicochemical properties for efficient drug design","volume":"6","author":"Goetz","year":"2018","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.biopha.2025.118537_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C7EM00099E","article-title":"Baseline toxicity and ion-trapping models to describe the pH-dependence of bacterial toxicity of pharmaceuticals","volume":"19","author":"Baumer","year":"2017","journal-title":"Environ. Sci. Process. Impacts"},{"key":"10.1016\/j.biopha.2025.118537_bib20","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/es015844c","article-title":"Baseline toxicity (narcosis) of organic chemicals determined by in vitro membrane potential measurements in energy-transducing membranes","volume":"36","author":"Escher","year":"2002","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.biopha.2025.118537_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpba.2011.11.033","article-title":"Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals","volume":"61","author":"Jiang","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2025.118537_bib22","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118537_bib23","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.2174\/1381612824666180808145320","article-title":"Aspects of Drug-Protein binding and methods of analyzing the phenomenon","volume":"24","author":"Wanat","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118537_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2015.03.011","article-title":"In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review","volume":"86","author":"Lambrinidis","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118537_bib25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.drudis.2016.07.007","article-title":"Quality guidelines for oral drug candidates: dose, solubility and lipophilicity","volume":"21","author":"Bayliss","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118537_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118537_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118537_bib28","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118537_bib29","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/jac\/dku171","article-title":"Bedaquiline: a review of human pharmacokinetics and drug-drug interactions","volume":"69","author":"van Heeswijk","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2025.118537_bib30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/PL00000897","article-title":"Cytochromes P450 and metabolism of xenobiotics","volume":"58","author":"Anzenbacher","year":"2001","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.biopha.2025.118537_bib31","first-page":"29","article-title":"The Ames salmonella\/microsome mutagenicity assay","volume":"455","author":"Mortelmans","year":"2000","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2025.118537_bib32","doi-asserted-by":"crossref","first-page":"14526","DOI":"10.1021\/acs.jmedchem.1c01049","article-title":"Structural and activity relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as antitubercular agents","volume":"64","author":"Fan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118537_bib33","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/acs.jmedchem.9b00912","article-title":"Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and their trifluoromethyl analogues as highly efficient antitubercular agents inhibiting Decaprenylphosphoryl-\u03b2-d-ribofuranose 2\u2019-Oxidase","volume":"62","author":"Karabanovich","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118537_bib34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/acs.jmedchem.5b00608","article-title":"Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating mycobacterium tuberculosis","volume":"59","author":"Karabanovich","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118537_bib35","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1016\/j.bmcl.2014.09.060","article-title":"6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity","volume":"24","author":"Malinak","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118537_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112584","article-title":"The wide-spectrum antimicrobial effect of novel N-alkyl monoquaternary ammonium salts and their mixtures; the QSAR study against bacteria","volume":"206","author":"Soukup","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118537_bib37","unstructured":"Evotec. Microsomal Stability | Cyprotex ADME-Tox Solutions. Evotec AG, (n.d.). Available at: \u3008https:\/\/www.evotec.com\/drug-metabolism\/microsomal-stability\u3009 (accessed June 10, 2025)."},{"key":"10.1016\/j.biopha.2025.118537_bib38","first-page":"151","article-title":"Biomimetic properties and estimated in vivo distribution of chloroquine and hydroxy-chloroquine enantiomers","volume":"9","author":"Valko","year":"2020","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.biopha.2025.118537_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43708-4","article-title":"Menthol- and thymol-based ciprofloxacin derivatives against mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies","volume":"13","author":"Szulczyk","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118537_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2022.107183","article-title":"Use of biomimetic chromatography and in vitro assay to develop predictive GA-MLR model for use in drug-property prediction among anti-depressant drug candidates","volume":"175","author":"Ulenberg","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.biopha.2025.118537_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462666","article-title":"Prediction of the chromatographic hydrophobicity index with immobilized artificial membrane chromatography using simple molecular descriptors and artificial neural networks","volume":"1660","author":"Ciura","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2025.118537_bib42","first-page":"191","article-title":"Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements","volume":"9","author":"Stergiopoulos","year":"2021","journal-title":"Admet Dmpk"},{"key":"10.1016\/j.biopha.2025.118537_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2008.137","article-title":"Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approach","volume":"6","author":"Piper","year":"2008","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.biopha.2025.118537_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-1161(83)90010-9","article-title":"Revised methods for the salmonella mutagenicity test","volume":"113","author":"Maron","year":"1983","journal-title":"Mutat. Res."},{"key":"10.1016\/j.biopha.2025.118537_bib45","article-title":"Microbial mutagenicity assay: Ames test","volume":"8","author":"Vijay","year":"2018","journal-title":"BioProtoc."},{"key":"10.1016\/j.biopha.2025.118537_bib46","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:50:25Z","timestamp":1772848225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":46,"alternative-id":["S0753332225007310"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118537","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118537","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118537"}}